fddnp
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2010 (NCT02243982)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 3-hydrogen
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f fddnp
- 18f fddnp
- fddnp
- fddnp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02003183 | Phase 2 | Mar 1, 2013 | University of California, Los Angeles |
| NCT02214862 | Early Phase 1 (Phase 1) | Mar 1, 2013 | Fundació per a la Recerca Biomedica, University of Barcelona |
| NCT02243982 | Early Phase 1 (Phase 1) | Mar 31, 2010 | Fundació per a la Recerca Biomedica, University of Barcelona |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fundació per a la Recerca Biomedica | Academic/Hospital | 2 | 0 | 1 | 2010 |
| University of Barcelona | Academic/Hospital | 2 | 2 | 1 | 2010 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1